CompletedPhase 4

Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections

Egypt141 participantsStarted 2022-01-01

Plain-language summary

The study hypothesizes that addition of dexmedetomidine to bupivacaine either in spinal anesthesia or TAP block is more effective and provide better ObsQor-11score than bupivacaine alone. Also, Dexmedetomidine in TAP block might provide a longer pain free time in comparison to intrathecal dexmedetomidine.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants will be full-term pregnant females * ASA classification I or ll. * Aged between 18 and 40 years. * Singleton pregnancy Exclusion Criteria: * Refusal of block. * Bleeding disorders (platelets count \<150,000; INR\>1.5; PC\<60%). * wounds or infection at the puncture site. * Known allergy to local anesthetic drugs. * Contraindications to neuroaxial block. * Contraindications to TAP block..

What they're measuring

Quality of recovery score following CS (ObsQor-11) at the end of the first 24 hours postoperative.

Timeframe: 24 hours postoperative

Trial details

NCT IDNCT05991466

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-30

View on ClinicalTrials.gov More The Quality of Recovery (ObsQOR-11) trials